These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25424957)

  • 61. Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study.
    Wagner C; Popp W; Posch M; Vlasich C; Rosenberger-Spitzy A
    Gerontology; 2003; 49(4):246-50. PubMed ID: 12792160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP).
    Klett-Tammen CJ; Krause G; Seefeld L; Ott JJ
    BMC Public Health; 2016 Feb; 16():121. PubMed ID: 26846202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Benedict Kpozehouen E; Macintyre CR; Tan TC
    Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Coverage rate and adverse reactions of National Immunization Program vaccines in children with spinal muscular atrophy: a cross-sectional retrospective cohort study].
    Qu YJ; Tian YL; Song F; Wang J; Bai JL; Cao YY; Jin YW; Wang H; Cheng MM
    Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):308-313. PubMed ID: 32234138
    [No Abstract]   [Full Text] [Related]  

  • 65. Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India.
    Ghia C; Wasserman M; Fletcher M; Farkouh R; Rambhad G
    Value Health Reg Issues; 2018 May; 15():99-105. PubMed ID: 29655052
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Infectious diseases in Poland in 2016.
    Sadkowska-Todys M; Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2018; 72(2):129-141. PubMed ID: 30111085
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.
    Kurai D; Mizukami A; Preckler V; Verelst F; Molnar D; Matsuki T; Ho Y; Igarashi A
    Expert Rev Vaccines; 2024; 23(1):303-311. PubMed ID: 38426479
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promoting Healthy Ageing in South Africa Through Vaccination of the Elderly.
    Sibanda M; Meyer JC; Mahlaba KJ; Burnett RJ
    Front Public Health; 2021; 9():635266. PubMed ID: 33981664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Reasons for adult immunization -- prevention of most frequent respiratory infections].
    Ludwig E
    Orv Hetil; 2014 Nov; 155(44):1743-7. PubMed ID: 25344851
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study.
    Domínguez A; Soldevila N; Toledo D; Godoy P; Torner N; Force L; Castilla J; Mayoral JM; Tamames S; Martín V; Egurrola M; Sanz F; Astray J;
    Hum Vaccin Immunother; 2016 Jul; 12(7):1891-9. PubMed ID: 27064311
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.
    Christenson B; Hedlund J; Lundbergh P; Ortqvist A
    Eur Respir J; 2004 Mar; 23(3):363-8. PubMed ID: 15065822
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Noninfluenza vaccination coverage among adults - United States, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Feb; 62(4):66-72. PubMed ID: 23364272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Important infections in elderly persons.
    Yoshikawa TT
    West J Med; 1981 Dec; 135(6):441-5. PubMed ID: 7039132
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease.
    Nichol KL
    Vaccine; 1999 Jul; 17 Suppl 1():S91-3. PubMed ID: 10471189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients.
    Naito T; Suzuki M; Kanazawa A; Takahashi H; Fujibayashi K; Yokokawa H; Kuwatsuru R; Watanabe A
    J Infect Chemother; 2020 Jul; 26(7):715-721. PubMed ID: 32334952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican people.
    Salinas-Rodríguez A; Manrique-Espinoza BS
    BMC Int Health Hum Rights; 2013 Jul; 13():30. PubMed ID: 23835202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Communicable disease mortality: now you see it, now you don't.
    Plaut RR; Silvi JJ
    J Public Health Policy; 1991; 12(4):464-74. PubMed ID: 1802890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adolescent vaccines: Need special focus in India.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2015; 11(12):2880-2. PubMed ID: 25483670
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.